These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25674930)

  • 1. Continuous processing for production of biopharmaceuticals.
    Rathore AS; Agarwal H; Sharma AK; Pathak M; Muthukumar S
    Prep Biochem Biotechnol; 2015; 45(8):836-49. PubMed ID: 25674930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatography bioseparation technologies and in-silico modelings for continuous production of biotherapeutics.
    Behere K; Yoon S
    J Chromatogr A; 2020 Sep; 1627():461376. PubMed ID: 32823091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous downstream processing of biopharmaceuticals.
    Jungbauer A
    Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.
    Steinebach F; Müller-Späth T; Morbidelli M
    Biotechnol J; 2016 Sep; 11(9):1126-41. PubMed ID: 27376629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling and process analytical technology for continuous chromatography of biopharmaceutical products.
    Khanal O
    Curr Opin Biotechnol; 2022 Dec; 78():102796. PubMed ID: 36152423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study.
    Kateja N; Agarwal H; Hebbi V; Rathore AS
    Biotechnol Prog; 2017 Jul; 33(4):998-1009. PubMed ID: 27977908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic assessment of continuous processing for manufacturing of biotherapeutics.
    Gupta P; Kateja N; Mishra S; Kaur H; Rathore AS
    Biotechnol Prog; 2021 Mar; 37(2):e3108. PubMed ID: 33305493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enablers of continuous processing of biotherapeutic products.
    Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
    Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production.
    Walther J; Godawat R; Hwang C; Abe Y; Sinclair A; Konstantinov K
    J Biotechnol; 2015 Nov; 213():3-12. PubMed ID: 26014522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous downstream processing for high value biological products: A Review.
    Zydney AL
    Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Paper on Continuous Bioprocessing May 20-21 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-820. PubMed ID: 28756843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
    Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
    J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.